Potential antivirals and antiviral strategies against SARS coronavirus infections.
about
Therapeutic and prevention strategies against human enterovirus 71 infectionAdvances in antivirals for non-influenza respiratory virus infections.The management of coronavirus infections with particular reference to SARS.Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity.Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor.Is the anti-psychotic, 10-(3-(dimethylamino)propyl)phenothiazine (promazine), a potential drug with which to treat SARS infections? Lack of efficacy of promazine on SARS-CoV replication in a mouse modelTherapies for coronaviruses. Part 2: Inhibitors of intracellular life cycle.Chronic beta-AR activation-induced calpain activation and impaired eNOS-Akt signaling mediates cardiac injury in ovariectomized female rats.Antiviral activity of four types of bioflavonoid against dengue virus type-2Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapyChloroquine interferes with dengue-2 virus replication in U937 cells.Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice.Lectins as Promising Therapeutics for the Prevention and Treatment of HIV and Other Potential Coinfections.Protein glycosylation in infectious disease pathobiology and treatmentPathobiology of virus glycosylation: implications to disease and prospects for treatment
P2860
Q28080796-EC8A1950-36AC-496E-A522-9B2B87558824Q30457132-8F10718F-8889-480F-A866-75CED1FCF27AQ34012358-A1998838-1486-4494-9944-714F868C55F5Q35911482-C612566E-8F06-4ADF-8A42-676327F9744AQ35973652-8BE9CE27-E342-4A1D-BD46-6EB0CEBDA43CQ36972801-D1B05E5A-F3EC-4167-B081-A490EDE171CDQ37481314-567BAB71-0B96-4567-A9FA-024D10F6E521Q37486435-03FE78DD-B1F7-4874-B93E-67FE03DC1F8FQ39622540-FFDE3614-E712-47DF-AB42-D3623B22303CQ39727842-F7321E2E-36AA-49ED-A776-A0DE6780C17CQ40208955-AE88AA76-972A-4B1B-906A-EAE0F5C75CFEQ41943954-B18D1494-58A9-468B-819D-108176A19027Q55120164-EA9EF9B6-3A38-49B9-AB8D-DC24A9EE87ECQ57202107-1D0C7474-3FE1-4191-A9DD-C3527219F3DEQ57202110-390DB699-808A-4018-B3A6-6BDFBBE6AAE5
P2860
Potential antivirals and antiviral strategies against SARS coronavirus infections.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Potential antivirals and antiviral strategies against SARS coronavirus infections.
@ast
Potential antivirals and antiviral strategies against SARS coronavirus infections.
@en
type
label
Potential antivirals and antiviral strategies against SARS coronavirus infections.
@ast
Potential antivirals and antiviral strategies against SARS coronavirus infections.
@en
prefLabel
Potential antivirals and antiviral strategies against SARS coronavirus infections.
@ast
Potential antivirals and antiviral strategies against SARS coronavirus infections.
@en
P2860
P356
P1476
Potential antivirals and antiviral strategies against SARS coronavirus infections.
@en
P2860
P304
P356
10.1586/14787210.4.2.291
P577
2006-04-01T00:00:00Z